FDA approves new Roche direct detection of West Nile Virus in donated human blood

Roche Diagnostics announced that the US Food & Drug Administration (FDA) has approved its biologics license application for the company's test for direct detection of West Nile Virus in donated human blood and plasma.

West Nile virus, which can cause serious health issues, is transmitted to humans most often through mosquito bites, but can also less commonly be transmitted by transfusion of infected blood or blood products. The test, called the cobas TaqScreen West Nile Virus Test, enables detection of the virus earlier in the infection cycle in donors who may show no symptoms of disease. According to the CDC, blood screening centers across the United States identified 340 donors whose blood tested positive for West Nile Virus in 2006 and 23 to date in 2007.

"We are pleased to offer US blood banks a new choice for both maximizing blood safety and optimizing efficiency," said Daniel O'Day, Head of Roche Molecular Diagnostics, the business area of Roche Diagnostics which developed the test. "The Roche test, run under an investigational new drug application by 14 clinical trial sites testing blood from a network of more than a 100 donation centers, helps blood banks streamline workflow and improve test results accuracy with reduced hands-on time, ready-to-use reagents, and full automation of each step."

The test is designed to run on the cobas s 201 system, Roche's flexible, modular instrument platform which automates each step of the real-time PCR blood screening process. The test uses Roche's highly sensitive polymerase chain reaction technology (PCR), the world's leading nucleic acid amplification technology, to detect the genetic material of the West Nile virus directly in blood. The United States Centers for Disease Control (CDC) has stated that screening donated blood for West Nile Virus by nucleic acid amplification tests has markedly reduced the risk of transfusion transmission.

Most people infected with West Nile Virus never show signs of illness or experience several days of flu-like symptoms, but others, especially those with compromised immune systems, can suffer serious and in some cases life threatening reactions. According to the US Centers for Disease Control, in 2002, transfusion-associated transmission (TAT) of West Nile virus (WNV) infection acquired through blood transfusion marked the emergence of a new threat to the U.S. blood supply. Although mosquito-borne transmission remains the predominant mode of WNV transmission, identification of TAT underscored the need for WNV screening of donated blood. In June 2003, blood-collection agencies implemented investigational WNV nucleic acid-amplification tests (NATs) to screen all blood donations and identify potentially infectious donations for quarantine and retrieval. This screening was performed on approximately 6 million units during June--December 2003, resulting in the removal of at least 818 viremic blood donations from the blood supply in 2003 alone.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Roche Diagnostics Limited. (2019, June 19). FDA approves new Roche direct detection of West Nile Virus in donated human blood. News-Medical. Retrieved on July 07, 2022 from https://www.news-medical.net/news/2007/08/29/29216.aspx.

  • MLA

    Roche Diagnostics Limited. "FDA approves new Roche direct detection of West Nile Virus in donated human blood". News-Medical. 07 July 2022. <https://www.news-medical.net/news/2007/08/29/29216.aspx>.

  • Chicago

    Roche Diagnostics Limited. "FDA approves new Roche direct detection of West Nile Virus in donated human blood". News-Medical. https://www.news-medical.net/news/2007/08/29/29216.aspx. (accessed July 07, 2022).

  • Harvard

    Roche Diagnostics Limited. 2019. FDA approves new Roche direct detection of West Nile Virus in donated human blood. News-Medical, viewed 07 July 2022, https://www.news-medical.net/news/2007/08/29/29216.aspx.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post
You might also like...
India gives Roche Diagnostics the license to conduct coronavirus tests, looks to delay disease progression